AAPL288.37+6.63 (+2.35%) ▲|ABBV251.95-2.37 (-0.93%) ▼|ABT91.04-1.68 (-1.81%) ▼|ACN123.78-0.96 (-0.77%) ▼|ADBE202.94-3.49 (-1.69%) ▼|AMAT734.71+40.07 (+5.77%) ▲|AMD579.42+39.93 (+7.40%) ▲|AMGN361.56+1.01 (+0.28%) ▲|AMT165.18-3.49 (-2.07%) ▼|AMZN238.75-1.39 (-0.58%) ▼|AVGO375.45+3.00 (+0.80%) ▲|AXP337.67-3.22 (-0.94%) ▼|BA216.21+1.52 (+0.71%) ▲|BAC57.25-0.64 (-1.10%) ▼|BKNG179.08-3.33 (-1.83%) ▼|BLK960.13+9.96 (+1.05%) ▲|BMY57.93-0.63 (-1.08%) ▼|BNY145.06+1.26 (+0.88%) ▲|BRK-B497.96+1.96 (+0.39%) ▲|C140.62-1.87 (-1.31%) ▼|CAT1,069.75+36.56 (+3.54%) ▲|CL91.86-0.54 (-0.58%) ▼|CMCSA24.37+0.15 (+0.60%) ▲|COF201.15-1.13 (-0.56%) ▼|COP104.12-0.08 (-0.08%) ▼|COST936.84-9.84 (-1.04%) ▼|CRM156.03-1.90 (-1.20%) ▼|CSCO117.28-0.42 (-0.36%) ▼|CVS103.93+0.35 (+0.34%) ▲|CVX167.01-1.46 (-0.87%) ▼|DE634.41+9.40 (+1.50%) ▲|DHR190.84-1.94 (-1.01%) ▼|DIS96.57-1.31 (-1.34%) ▼|DUK127.68-0.65 (-0.51%) ▼|EMR143.72+0.90 (+0.63%) ▲|FDX311.12-14.28 (-4.39%) ▼|GD352.88+4.81 (+1.38%) ▲|GE368.93-4.78 (-1.28%) ▼|GEV1,162.31+59.80 (+5.42%) ▲|GILD126.05-0.28 (-0.22%) ▼|GM76.57-0.78 (-1.00%) ▼|GOOG353.14+1.86 (+0.53%) ▲|GOOGL356.18+2.53 (+0.72%) ▲|GS1,013.39-6.83 (-0.67%) ▼|HD352.23+1.42 (+0.40%) ▲|HON224.07-3.73 (-1.64%) ▼|IBM280.39+2.39 (+0.86%) ▲|INTC141.86+10.14 (+7.70%) ▲|INTU261.90-4.51 (-1.69%) ▼|ISRG400.45-5.52 (-1.36%) ▼|JNJ256.31-2.20 (-0.85%) ▼|JPM328.81-0.58 (-0.18%) ▼|KO81.90-0.76 (-0.91%) ▼|LIN521.58+10.52 (+2.06%) ▲|LLY1,210.15-19.78 (-1.61%) ▼|LMT505.37+3.30 (+0.66%) ▲|LOW219.70+0.05 (+0.02%) ▲|LRCX434.39+23.48 (+5.71%) ▲|MA511.82+2.18 (+0.43%) ▲|MCD270.52+3.34 (+1.25%) ▲|MDLZ58.51-1.65 (-2.73%) ▼|MDT78.82-2.11 (-2.61%) ▼|META560.14-2.46 (-0.44%) ▼|MMM161.47-0.97 (-0.59%) ▼|MO72.75-1.30 (-1.75%) ▼|MRK128.34-1.04 (-0.80%) ▼|MS209.36-2.36 (-1.11%) ▼|MSFT371.16+2.59 (+0.70%) ▲|MU1,154.96+9.68 (+0.85%) ▲|NEE88.24-0.43 (-0.48%) ▼|NFLX72.44-1.35 (-1.82%) ▼|NKE41.53+0.05 (+0.12%) ▲|NOW97.50-2.47 (-2.47%) ▼|NVDA198.24+3.27 (+1.68%) ▲|ORCL146.39-1.38 (-0.93%) ▼|PEP136.73-1.95 (-1.41%) ▼|PFE24.14-0.23 (-0.94%) ▼|PG146.45-2.00 (-1.35%) ▼|PLTR117.94+2.24 (+1.94%) ▲|PM181.01-1.86 (-1.01%) ▼|QCOM185.97-2.75 (-1.46%) ▼|RTX187.92+0.59 (+0.32%) ▲|SBUX103.01-1.05 (-1.01%) ▼|SCHW92.35+1.80 (+1.99%) ▲|SO96.46-0.29 (-0.30%) ▼|SPG224.76-2.81 (-1.23%) ▼|T20.76-1.07 (-4.88%) ▼|TMO502.51-3.91 (-0.77%) ▼|TMUS168.35-5.62 (-3.23%) ▼|TSLA416.90+5.06 (+1.23%) ▲|TXN297.42+11.94 (+4.18%) ▲|UBER72.82-2.68 (-3.55%) ▼|UNH416.40-3.42 (-0.81%) ▼|UNP272.73+0.03 (+0.01%) ▲|UPS107.42-0.60 (-0.55%) ▼|USB60.73-0.03 (-0.05%) ▼|V342.83+1.18 (+0.35%) ▲|VZ42.62-1.49 (-3.37%) ▼|WFC82.82-0.69 (-0.83%) ▼|WMT113.55-1.05 (-0.92%) ▼|XOM136.31+0.25 (+0.18%) ▲|AAPL288.37+6.63 (+2.35%) ▲|ABBV251.95-2.37 (-0.93%) ▼|ABT91.04-1.68 (-1.81%) ▼|ACN123.78-0.96 (-0.77%) ▼|ADBE202.94-3.49 (-1.69%) ▼|AMAT734.71+40.07 (+5.77%) ▲|AMD579.42+39.93 (+7.40%) ▲|AMGN361.56+1.01 (+0.28%) ▲|AMT165.18-3.49 (-2.07%) ▼|AMZN238.75-1.39 (-0.58%) ▼|AVGO375.45+3.00 (+0.80%) ▲|AXP337.67-3.22 (-0.94%) ▼|BA216.21+1.52 (+0.71%) ▲|BAC57.25-0.64 (-1.10%) ▼|BKNG179.08-3.33 (-1.83%) ▼|BLK960.13+9.96 (+1.05%) ▲|BMY57.93-0.63 (-1.08%) ▼|BNY145.06+1.26 (+0.88%) ▲|BRK-B497.96+1.96 (+0.39%) ▲|C140.62-1.87 (-1.31%) ▼|CAT1,069.75+36.56 (+3.54%) ▲|CL91.86-0.54 (-0.58%) ▼|CMCSA24.37+0.15 (+0.60%) ▲|COF201.15-1.13 (-0.56%) ▼|COP104.12-0.08 (-0.08%) ▼|COST936.84-9.84 (-1.04%) ▼|CRM156.03-1.90 (-1.20%) ▼|CSCO117.28-0.42 (-0.36%) ▼|CVS103.93+0.35 (+0.34%) ▲|CVX167.01-1.46 (-0.87%) ▼|DE634.41+9.40 (+1.50%) ▲|DHR190.84-1.94 (-1.01%) ▼|DIS96.57-1.31 (-1.34%) ▼|DUK127.68-0.65 (-0.51%) ▼|EMR143.72+0.90 (+0.63%) ▲|FDX311.12-14.28 (-4.39%) ▼|GD352.88+4.81 (+1.38%) ▲|GE368.93-4.78 (-1.28%) ▼|GEV1,162.31+59.80 (+5.42%) ▲|GILD126.05-0.28 (-0.22%) ▼|GM76.57-0.78 (-1.00%) ▼|GOOG353.14+1.86 (+0.53%) ▲|GOOGL356.18+2.53 (+0.72%) ▲|GS1,013.39-6.83 (-0.67%) ▼|HD352.23+1.42 (+0.40%) ▲|HON224.07-3.73 (-1.64%) ▼|IBM280.39+2.39 (+0.86%) ▲|INTC141.86+10.14 (+7.70%) ▲|INTU261.90-4.51 (-1.69%) ▼|ISRG400.45-5.52 (-1.36%) ▼|JNJ256.31-2.20 (-0.85%) ▼|JPM328.81-0.58 (-0.18%) ▼|KO81.90-0.76 (-0.91%) ▼|LIN521.58+10.52 (+2.06%) ▲|LLY1,210.15-19.78 (-1.61%) ▼|LMT505.37+3.30 (+0.66%) ▲|LOW219.70+0.05 (+0.02%) ▲|LRCX434.39+23.48 (+5.71%) ▲|MA511.82+2.18 (+0.43%) ▲|MCD270.52+3.34 (+1.25%) ▲|MDLZ58.51-1.65 (-2.73%) ▼|MDT78.82-2.11 (-2.61%) ▼|META560.14-2.46 (-0.44%) ▼|MMM161.47-0.97 (-0.59%) ▼|MO72.75-1.30 (-1.75%) ▼|MRK128.34-1.04 (-0.80%) ▼|MS209.36-2.36 (-1.11%) ▼|MSFT371.16+2.59 (+0.70%) ▲|MU1,154.96+9.68 (+0.85%) ▲|NEE88.24-0.43 (-0.48%) ▼|NFLX72.44-1.35 (-1.82%) ▼|NKE41.53+0.05 (+0.12%) ▲|NOW97.50-2.47 (-2.47%) ▼|NVDA198.24+3.27 (+1.68%) ▲|ORCL146.39-1.38 (-0.93%) ▼|PEP136.73-1.95 (-1.41%) ▼|PFE24.14-0.23 (-0.94%) ▼|PG146.45-2.00 (-1.35%) ▼|PLTR117.94+2.24 (+1.94%) ▲|PM181.01-1.86 (-1.01%) ▼|QCOM185.97-2.75 (-1.46%) ▼|RTX187.92+0.59 (+0.32%) ▲|SBUX103.01-1.05 (-1.01%) ▼|SCHW92.35+1.80 (+1.99%) ▲|SO96.46-0.29 (-0.30%) ▼|SPG224.76-2.81 (-1.23%) ▼|T20.76-1.07 (-4.88%) ▼|TMO502.51-3.91 (-0.77%) ▼|TMUS168.35-5.62 (-3.23%) ▼|TSLA416.90+5.06 (+1.23%) ▲|TXN297.42+11.94 (+4.18%) ▲|UBER72.82-2.68 (-3.55%) ▼|UNH416.40-3.42 (-0.81%) ▼|UNP272.73+0.03 (+0.01%) ▲|UPS107.42-0.60 (-0.55%) ▼|USB60.73-0.03 (-0.05%) ▼|V342.83+1.18 (+0.35%) ▲|VZ42.62-1.49 (-3.37%) ▼|WFC82.82-0.69 (-0.83%) ▼|WMT113.55-1.05 (-0.92%) ▼|XOM136.31+0.25 (+0.18%) ▲|
32 C
New York
Tuesday, June 30, 2026

Tag: research

newssourceFORcompanyinformationcontent1releasesmarket

CYRIN Has Added a New Timely Lab – “The Fundamentals of Cryptography”

EDEN PRAIRIE, Minn., Aug. 14, 2025 /PRNewswire/ -- CYRIN, the virtual cybersecurity platform from ATCorp., has added a new scenario that deals with the fundamentals...

Zifo Launches AI Antibody Engineering App on Snowflake Marketplace to Accelerate Biologics and Drug Discovery

Zifo accelerates antibody engineering and therapeutics development with launch of AI-Powered Protein Models on Snowflake CAMBRIDGE, Mass., CAMBRIDGE, England and CHENNAI, India, Aug. 14,...

Psychedelic Drugs Market Research Report 2025-2033 | Rising Demand for Non-Hallucinogenic Psychedelics Expands Patient Base, Breakthrough Regulatory Designations Accelerate Approvals

Key opportunities in the psychedelic drugs market include rising demand for mental health treatments, especially for conditions like depression and PTSD. Advances in clinical trials and regulatory support enhance acceptance, while integration with digital health tools augments care. Global policy reforms and decriminalization further bolster growth prospects. 
Key opportunities in the psychedelic drugs market include rising demand for mental health treatments, especially for conditions like depression and PTSD. Advances in clinical trials and regulatory support enhance acceptance, while integration with digital health tools augments care. Global policy reforms and decriminalization further bolster growth prospects.

TransUnion Finds U.S. Consumer Credit Market Showing Signs of Stability and Measured Growth at Mid-Point of 2025

Q2 2025 TransUnion Credit Industry Insights Report explores the latest credit trends 
Q2 2025 TransUnion Credit Industry Insights Report explores the latest credit trends

Edible Garden Delivers Strong Performance Across Core and Key Segments, Driven by Strategic Portfolio Transformation

 Company exits low-margin product lines, invests in higher-margin, innovative CEA-informed, better-for-you shelf-stable products, and expands global reach

Cellebrite Announces Second-Quarter 2025 Results

Thomas E. Hogan Named CEO

Shattuck Labs Reports Second Quarter 2025 Financial Results and Recent Business Highlights

– Submitted Investigational New Drug (IND) application to evaluate SL-325 in a Phase 1 clinical trial in healthy volunteers; clearance expected in Q3 2025 –

Gimme Credit: Corporate Bonds Stay Strong as U.S. Tariffs and Consumer Caution Test Market

NEW YORK, Aug. 14, 2025 /PRNewswire/ -- Gimme Credit's latest research shows that leading U.S. corporate issuers are holding firm against escalating tariffs and increasingly...

Allot Announces Second Quarter 2025 Financial Results

Exceptionally strong 73% year-over-year growth in SECaaS ARR; raising full year guidance HOD HASHARON, Israel, Aug. 14, 2025 /PRNewswire/ -- Allot Ltd. (NASDAQ: ALLT) (TASE: ALLT),...

As Agentic AI Gains Traction, 86% of Enterprises Anticipate Heightened Risks, Yet Only 2% of Companies Meet Responsible AI Gold Standards

With 95% of enterprises facing incidents, Infosys research reveals wide gap between AI adoption and responsible AI readiness, exposing most enterprises to reputational risks...

22nd Century Group Reports Second Quarter 2025 Financial Results

VLN® Early Adoption Commercial Activity Expands with Two Partner Brand Launches in Progress – Smoker Friendly and Pinnacle

Guidehouse Research Estimates Market for Energy Service Companies’ Performance Contracting to Reach Nearly $27 Billion by 2034

ESCO performance contracts gain traction as governments and businesses seek long-term energy savings and resilience BOULDER, Colo., Aug. 14, 2025 /PRNewswire/ -- A new report from Guidehouse...

GAR Reaches Record High First-Half Revenue, Standing Firm Against Market Headwinds

GAR's revenue reached a first-half record high of US$6.2 billion, supported by a 19% increase in crude palm oil (CPO) market prices1H 2025 EBITDA...

Am Weltorganspendetag gibt das KFSHRC die Durchführung von 10 Nierentransplantationen innerhalb von 48 Stunden bekannt

RIAD, Saudi-Arabien, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Das King Faisal Specialist Hospital and Research Centre (KFSHRC) hat an zwei aufeinanderfolgenden Tagen erfolgreich 10 Cross-Over-Nierentransplantationen durchgeführt und damit einen weltweiten Rekord für die meisten derartigen Eingriffe innerhalb von zwei Tagen in einem einzigen Zentrum aufgestellt – zeitgleich mit dem Weltorganspendetag am 13. August. Dieser Meilenstein unterstreicht die führende Rolle des KFSHRC im Bereich der Organtransplantation weltweit.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsResearch

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers